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   bjective: The aim of the present study was to evaluate the efficacy of low-level laser therapy (LLLT) and the microelectric neurostimulation
(MENS) in the treatment of patients with temporomandibular disorders (TMD). Material and methods: A sample of 19 individuals
presenting with signs and symptoms of myogenic TMD was randomly divided into two groups (I – LLLT and II – MENS). Therapy was
done in 10 sessions, three times a week, for one month. Patients were evaluated by the Visual Analogue Scale (VAS), measurement of active
range of motion (AROM) and muscle palpation, performed immediately before and 5 minutes after each therapeutic session by a blinded
TMD specialist. The ANOVA for repeated measurements and Mann-Whitney tests were used for the statistical analysis. Results: The
results showed an increase in maximum mouth opening and a decrease in tenderness to palpation for both groups. The VAS reduced for both
groups, although more evident for the laser group (p<0.05). Conclusion: Authors concluded that both therapies were effective as part of the
TMD treatment, and the cumulative effect may have been responsible for this fact. However, caution is recommended when judging the
results due to the self-limiting aspect of musculoskeletal conditions such as TMD.
Uniterms: Low-level laser therapy (LLLT); Temporomandibular joint disorders; Randomized controlled trials; Microelectric neurostimulation.
  bjetivo: Avaliar a efetividade do laser de baixa freqüência e do estímulo muscular microelétrico (MENS) no tratamento de pacientes com
disfunções temporomandibulares (DTM). Material e Métodos: Uma amostra de 19 indivíduos com sinais e sintomas de DTM de origem
muscular, foi dividida em dois grupos (I –laser e II – MENS). O tratamento consistiu de 10 sessões, três vezes por semana, durante um mês.
Os critérios de avaliação dos pacientes foram: escala de análise visual (EAV), mensuração de abertura máxima bucal e palpação muscular, estes
foram avaliados imediatamente antes e 5 minutos após cada sessão terapêutica, num estudo do tipo controlado. Para análise estatística, foram
aplicados ANOVA para mensurações repetidas e Mann-Whitney. Resultados: Os resultados demonstraram aumento da abertura bucal
máxima e diminuição na sensibilidade à palpação em ambos os grupos e, em relação à EAV, ambos os grupos demonstraram decréscimo, mas
houve uma diferença estatisticamente significante entre os grupos, já que o grupo laser apresentou os melhores resultados p<0,05. Conclusão:
Os autores concluíram que as duas terapias foram efetivas como parte do tratamento das DTM, e o efeito cumulativo podem ter sido
responsável pela melhora. Porém sugere-se cautela quando se analisam os resultados devido ao aspecto autolimitante das condições músculo-
esqueletais como as DTM.
Unitermos: Terapia a laser de baixa intensidade; Transtornos da articulação temporomandibular; Ensaios controlados aleatórios.
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INTRODUCTION
Combined therapies have been proposed in the
management of symptoms of TMD. This interdisciplinary
approach is necessary because of the multifactorial aspect
of these problems. Different forms of treatments other than
the historical occlusal are part of the global management
and are known as supportive therapy27.
According to Ogus and Tooller26 (1986) and Guralnick16
(1984), TMD management is more effective when patient is
treated according to a logical sequence of importance, i.e.:
treatment of the symptoms, of the underlying cause, of the
predisposing factors, and eventually treatment of the
pathological effects. Physical therapy has been used for
many years as a support therapy. To increase patient’s
awareness of the cause of symptoms, to achieve muscle
relaxation, to reduce muscle hyperactivity, reestablishing
joint movement, to relieve pain, and to allow a normal
function are common physical therapy goals and objectives.
Microcurrent therapy (MENS) and soft laser are some of
these modalities.
Different theories are know to explain the mechanism of
action of microcurrent therapy: 1) It provides ATP (adenosine
triphosphate) to the cells, which is very important due to its
participation in the mechanisms of contraction and relaxation
of the muscle tissue, as well as for protein synthesis and
cell reproduction4. 2) Application of low-frequency currents
is biologically compatible with the physiological currents
penetrating the cell, providing an electrochemical balance
and restoring the electrophysiological state of the
traumatized cell. In response to that, a decreased nociceptive
message reaches the Central Nervous System (CNS), altering
the painful sensation. This modality has been indicated in
the treatment of myogenic pain, Temporomandibular Joint
(TMJ) Disorders, edema reduction, etc.
On the other hand, low-level laser therapy (LLLT) has
analgesic, antiedematous and biostimulating
effects12,18,19,23,28,29. The most common types are the helium-
neon laser (He-Ne gas) and the infrared laser with diode of
gallium-arsenium (Ga-As) or gallium-aluminum-arsenium (Ga-
Al-As).
Literature has recommended the use of these modalities
as supportive for TMD treatment. Bertolucci and Grey2 (1995)
compared the effect of MENS, Mid-laser and placebo in the
treatment of patients with pain associated to active joint
dysfunction of the TMJ. Authors observed that the MENS
and Mid-laser were effective for reducing pain and improving
mandibular movement. Mid-laser was superior to MENS
concerning application and effect, and both were
significantly better than the placebo treatment. Du Pont Jr6,
in 1999, described a protocol for the use of microcurrent in
the identification of trigger points and treatment of
myofascial pain.
Macedo and Mello22 (2002) evaluated the efficacy of the
hydrostatic splint AqualizerTM, MENS and TENS
(transcutaneous electrical neural stimulation) therapies in
patients with TMD in acute situations and concluded that
the MENS and the hydrostatic splint were more effective
than TENS. In the same year, Guimarães, et al.15, in a pilot
study, evaluated the clinical efficacy of electrotherapy
employing TENS and MENS in a sample of 14 patients.
Authors reported significant improvements when MENS
therapy was used. Bezuur, Habets, Hansson3 (1988), found
that the low-level laser therapy (LLLT) was effective after a
short period of treatment and was still stable after one-year
follow-up for patients with arthrogenic TMD. Conti5 (1997),
evaluated the efficacy of the low-level laser therapy in TMD
by means of a double-blind placebo controlled study. The
author observed an improvement of pain report for patients
with myogenic pain, while improved mandibular movement
was found for arthrogenic patients.
Beckerman, et al.1 (1992), studied the efficacy of laser
therapy in musculoskeletal disorders in a meta-analysis and
concluded that the treatment with low-level laser provided
more reliable results for pain treatment in double blind
protocols. In a similar publication, however, Gam, Thorsen
and Lonnberg11 (1993), concluded that the low-level laser
therapy is not effective for musculoskeletal disorders.
Tullberg, Alstergren and Enberg32 (2003) also reported that
the pain intensity was not affected by the laser exposure,
while Kitchen and Partridge21 (1991) were unable to draw
conclusions, because the results differed greatly between
trials, as did the types of lasers used and the doses.
Therefore, the aim of this study is to evaluate the efficacy
of low-level laser therapy (LLLT) and microcurrent therapy
(MENS) in the treatment of myogenic TMD patients.
MATERIAL AND METHODS
A sample of 19 women (mean age 26.4 years) was selected
among those attending the Orofacial Pain Center of the
Department of Prosthodontics, Bauru Dental School
(University of São Paulo), Brazil.
The entire sample was informed on the objectives of the
study and an informed consent term, in agreement with the
Regulation #196/96 of the Brazilian National Health Council,
was signed.
Initial clinical examination included anamnesis and
detailed physical inspection, comprising muscle and TMJ
palpation, evaluation of the mandibular movement and joint
sounds. Inclusion criteria was the presence of myofascial
pain, according to the Research Diagnostic Criteria for TMD7
and tenderness to palpation in the masseter or anterior
temporalis.
Patients with TMJ pain, systemic diseases (e.g.
rheumatoid arthritis, fibromyalgia)5,32, previous treatment for
TMD, occlusal factors of risk, toothache, neuralgia or local
skin infection over the most tender spot of the masseter and
temporal muscles were excluded. The presence of major
psychological disturbances and restriction for the use of
LASER and MENS (e.g. pacemaker users) were also exclusion
criteria.
After initial evaluation and diagnosis, each patient was
randomly assigned either to group I (LLLT) (9 patients) or
group II (MENS), with 10 individuals. A research assistant
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carried out the selection of the patients in order to establish
a double-blind design. Randomization was done with the
help of a computer generated sequence of distribution. In
order to better distribute the sample as for VAS levels, a
stratification method was used during the randomization
process. After that similar levels for both groups were
obtained (4.4mm and 6.0mm for MENS and Laser,
respectively). A wash-out period (3 days without medication)
was requested to all participants before beginning of the
trial14. During the course of this study, patients were also
requested not to take analgesic drugs or to have any other
form of therapy.
Laser therapy was performed 3 times a week, in a total of
ten sessions, using a low-level laser device of Ga-Al-As
with wavelength of 830 to 904nm, with an output of 4 joules
per cm2 and power of 100mW (VR-KC-610 SOFT LASER –
Dentoflex, São Paulo-SP, Brazil).
Microcurrent therapy was also performed 3 times a week,
in a total of ten sessions, employing a MIOSOFT
MILLENNIUM MTC #17849 apparatus (DENTOFLEX, São
Paulo – SP, Brazil). Application was done for 20 minutes,
and the current frequency ranged from 40 to 160mA.
The main researcher applied the laser therapy, while
MENS was applied by a general practitioner. Moreover, a
TMD specialist conducted the physical evaluation of the
patients before and after each session. Each patient was
evaluated immediately before and five minutes after each
session, when the active mouth opening, TMJ and muscle
palpation, and Visual Analogue Scale (VAS) were evaluated.
The VAS is a measurement of pain, in which all individuals
scored their pain on a horizontal line measuring 100mm, where
the left end means “no pain” and the right end indicates
“the worst pain imaginable”.
With the RDC as a guide7, the muscle palpation was
performed bilaterally, with approximately 1.5kgf of pressure,
and it was graded from zero to three, depending on the
patient’s reaction to palpation.
The Student’s “t” test was used for intragroup analysis
and the three-way ANOVA for repeated measurements
evaluated differences between groups (LASER X
MIOSOFT), differences before and after each therapy
session (immediate effect) and differences between sessions.
The Mann-Whitney test was also used for intragroup
evaluation for tenderness to palpation. A significance level
of 5% was adopted.
RESULTS
Visual Analogue Scale (VAS)
The initial mean VAS for the laser (LLLT) and MENS
groups were 66.1mm and 44mm, respectively. Final figures
were 4.4mm and 6mm, respectively.
When within groups analysis was performed, both
groups had significant improvements for both VAS and
muscle palpation analysis (p<0.01). The laser group
demonstrated a more significant pain reduction (VAS) when
between groups analysis was done (p=0.01)
The progress of the treatment may be visualized in Figure
1, where an improvement before and after each session is
observed.
Active range of motion (AROM)
Figure 2 shows the maximal opening mean values for
both experimental groups during the treatment period. The
initial and final means of maximum opening for the LASER
group were 43mm and 47.6mm, respectively; while for the
MENS group were 46.3mm and 49.4mm. No significant
difference was found (p>0.05) between groups.
Muscle palpation
No significant difference between groups for muscle
palpation for both groups were found at both sides (p>0.05).
Variation of the pain condition for the anterior temporalis
and masseter at the right and left sides are seen in Figures 3,
4, 5 and 6, respectively.
FIGURE 1- Visual Analogue Scale for each study group,
before and after each therapy session
FIGURE 2- Mean maximum opening in millimeters for each
group, before and after each therapy session
FIGURE 3- Mean palpation figures (from 0 to 3) of the right
anterior temporal muscle, before and after each therapy
session
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DISCUSSION
The results of this study demonstrated a drop of the
pain report for both groups, when VAS was used. When
intragroup analysis is considered, however, the laser group
had a better outcome when compared to the MENS group,
in agreement with Bertolucci, et.al.2 (1995). This fact should
be interpreted with caution, since the whole sample has
reported a significant improvement in the final assessment.
Another issue to be considered is the different initial mean
VAS between groups (probably due to randomization), which
certainly influenced the final difference between both
modalities. When comparing the VAS reduction for both
groups, very similar figures are found (86% and 87% for
LLT and MENS groups, respectively).
Tenderness to muscle palpation has also decreased for
the whole sample, regardless of the group distribution.
Although not a true object finding, muscle palpation can be
result of a local tissue healing, consequence of both
therapies. It has been proposed that muscle pain occurs
due to hypoxia and energy deficit, then the better response
to muscle palpation could be due to stimulation of muscle
blood circulation. Tullberg, Alstergren and  Enberg32 ,
however, did not find any microcirculation change in the
masseter muscle, after the use of low-level laser therapy.
It is widely accepted that TMD symptoms are fluctuating
and self-limiting27. It means that many patients will exhibit a
natural and expected improvement, even if no therapy is
offered. This fact also should be considered when
interpreting the actual findings, since a placebo group was
not used as control, which is a limitation of the present
study. Some authors11,20,33,34  have reported good results for
placebo control groups when compared to “real”
electrotherapy. Feine and Lund8 (1997), after a critical
analysis of review articles about the efficacy of physical
therapy for the control of chronic musculoskeletal pain,
concluded that patients are helped during the period that
they are being treated with most forms of physical therapy,
however, most of these therapies have not been shown to
be more efficacious than placebo.
This is especially important in the field of chronic
diseases, as TMD, where even the initial contact between
patients and professionals can account for significant
improvements. In spite of these facts, the great advantages
of the techniques investigated are the non-invasive and
reversible features. Feine, Widmer and Lund9 (1997) reported
that these forms of reversible, noninvasive therapy are better
than no therapy, perhaps because patients do best when
clinicians take the time to fully inform them about their
condition and allay their fears.
It has also been reported that electrotherapy has few
side effects and is easy to apply2,13.
The use of laser as a modality of TMD treatment presents
several advantages, since it induces healing and allows for
tissue reorganization18,19,21. Besides, it provides fast
response, is user-friendly and may be employed for both
acute and chronic pain31. Wilder-Smith34 (1988), Okyayuz-
Baklouti28 (1989) and Hansen and Thoroe17 (1990) report
that the low-level laser provides beneficial cellular effects,
such as vasodilatation, edema reduction and stimulation of
healing.
Kitchen and Partridge21 (1991) also reported that the low-
level laser promotes cell alteration and proliferation,
phagocytosis and increased immune response. They also
stated that healing occurs by stimulation of macrophages,
mast cells degranulation, activation of fibroblasts, alteration
of cell membrane, angiogenesis and photodissociation of
oxyhemoglobins.
Macedo and Mello22 (2002) reported that 40% of patients
reported total remission of pain, after MENS therapy.
Bertolucci and Grey2 (1995) also found this therapy to be
superior to the placebo treatment in patients with
degenerative joint disease of the TMJ. Guimarães, et al.15
(2002) carried out an evaluation of MENS in 9 patients
suffering from TMD, observing a significant improvement
in acute cases. Also a higher rate of success of such
therapies may be reached when employing MENS combined
exercises.
The type of TMD should be carefully evaluated when
conclusions are drawn, since the outcomes may diverge,
depending on the characteristics of pain, either of muscular
FIGURE 4- Mean palpation figures (from 0 to 3) of the left
anterior temporal muscle, before and after each therapy
session
FIGURE 5- Mean of palpation figures of the right masseter
muscle, before and after each therapy session
FIGURE 6- Mean of palpation figures of the left masseter
muscle, before and after each therapy session
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or articular origin. Conti5 (1997), has found that laser therapy
improved only the mandibular movements in patients with
arthrogenic dysfunction, whereas it decreased the pain in
patients with myogenic disorder. On the other hand, Bezuur,
Habets and Hansson3 (1988) observed a pain relief in 36%
of myogenic patients, and up to 80% the patients with
arthrogenic pain.
The mandibular opening usually ranges from 53 to 58mm,
is smaller in women than in men10,24,30 and decreases with
age. It is considered limited if below 40mm, including the
overbite7,27. In the present study, the initial mean maximum
mouth opening of the whole sample was 44.65mm and the
final mean, after the ten sessions of therapy, was 48.5mm.
Obviously, the mouth opening restriction was not the primary
complaint of the sample, but the improvement in this feature
can be understood as a secondary effect of pain reduction,
result of LASER and MENS therapy. This fact is in agreement
with previous studies, when conservative methods were
tested7, 25.
CONCLUSIONS
1. Both therapies (LLLT and MENS) were effective in
the management of myogenic TMD, but caution is
recommended when analyzing such results, due to the self-
limiting aspect of the TMD.
2. Active mouth opening and muscle tenderness to
palpation have improved for both groups.
3. Longitudinal and controlled studies are necessary
to evaluate the real effect of physical therapy modalities on
TMD signs and symptoms.
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